Clinical trial
Phenylbutyrate/Genistein Duotherapy in Delta F508-Homozygous(for Cystic…
NCT00016744 · Children's Hospital of Philadelphia, Other · Completed
Key facts
| NCT number | NCT00016744 |
|---|---|
| Title | Phenylbutyrate/Genistein Duotherapy in Delta F508-Homozygous(for Cystic Fibrosis) |
| Official title | A Pilot Trial of Phenylbutyrate/Genistein Duotherapy in Delta F508-Homozygous Cystic Fibrosis Patients |
| Lead sponsor | Children's Hospital of Philadelphia, Other |
| Collaborators | Cystic Fibrosis Foundation National Center for Research Resources (NCRR) NIH |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Cystic Fibrosis |
| Intervention type | Drug |
| Interventions | Sodium 4-Phenylbutyrate (4PBA), Unconjugated Isoflavones 100 (PTI G-4660, 87% Genistein), Placebo |
| Enrollment | 12 |
| Start date | Sep 1, 2001 |
| Primary completion | Oct 1, 2005 |
| Completion | Oct 1, 2005 |
| First posted | Jun 4, 2001 |
| Last update posted | Jan 9, 2009 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: